BIOMAT Database Logo BIOMAT Database Logo

Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome). 1994

M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
Department of Neurology, University of Southern California, Los Angeles 90033.

We report a patient with Lubag (X-linked dystonia-parkinsonism) who presented with severe respiratory stridor from adductor laryngeal breathing dystonia. Emergency tracheostomy was necessary, and subsequent laryngeal injection with botulinum toxin led to worsening aspiration. Botulinum toxin injection for severe lingual dystonia was successful.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007818 Laryngeal Diseases Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing. Laryngeal Perichondritis,Larynx Diseases,Disease, Laryngeal,Disease, Larynx,Diseases, Laryngeal,Diseases, Larynx,Laryngeal Disease,Laryngeal Perichondritides,Larynx Disease,Perichondritides, Laryngeal,Perichondritis, Laryngeal
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D012120 Respiration Disorders Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available. Disorder, Respiration,Disorders, Respiration,Respiration Disorder
D012131 Respiratory Insufficiency Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed) Acute Hypercapnic Respiratory Failure,Acute Hypoxemic Respiratory Failure,Hypercapnic Acute Respiratory Failure,Hypercapnic Respiratory Failure,Hypoxemic Acute Respiratory Failure,Hypoxemic Respiratory Failure,Respiratory Depression,Respiratory Failure,Ventilatory Depression,Depressions, Ventilatory,Failure, Hypercapnic Respiratory,Failure, Hypoxemic Respiratory,Failure, Respiratory,Hypercapnic Respiratory Failures,Hypoxemic Respiratory Failures,Respiratory Failure, Hypercapnic,Respiratory Failure, Hypoxemic,Respiratory Failures
D012135 Respiratory Sounds Noises, normal and abnormal, heard on auscultation over any part of the RESPIRATORY TRACT. Breathing Sounds,Crackles,Lung Sounds,Pleural Rub,Rales,Rhonchi,Stridor,Wheezing,Breathing Sound,Crackle,Lung Sound,Pleural Rubs,Rale,Respiratory Sound,Rhonchus,Rub, Pleural,Sound, Breathing,Sound, Lung,Sound, Respiratory,Sounds, Breathing,Sounds, Lung,Stridors,Wheezings
D001905 Botulinum Toxins Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS. Botulin,Botulinum Neurotoxin,Botulinum Neurotoxins,Clostridium botulinum Toxins,Botulinum Toxin,Neurotoxin, Botulinum,Neurotoxins, Botulinum,Toxin, Botulinum,Toxins, Botulinum,Toxins, Clostridium botulinum

Related Publications

M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
Zolpidem improves dystonia in "Lubag" or X-linked dystonia-parkinsonism syndrome.
February 2002, Neurology,
M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
[Lubag syndrome (Xq13-linked dystonia-parkinsonism)].
January 1999, Ryoikibetsu shokogun shirizu,
M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
Neuropathology of lubag (x-linked dystonia parkinsonism).
July 1993, Movement disorders : official journal of the Movement Disorder Society,
M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
Phenomenology of "Lubag" or X-linked dystonia-parkinsonism.
November 2002, Movement disorders : official journal of the Movement Disorder Society,
M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
X-linked recessive dystonia parkinsonism (XDP; Lubag; DYT3).
January 2004, Advances in neurology,
M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
X-Linked Dystonia-Parkinsonism ("Lubag") May Present with Peripheral Synucleinopathy.
January 2022, Movement disorders : official journal of the Movement Disorder Society,
M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.
January 2013, The journal of medical investigation : JMI,
M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
X-linked dystonia ("Lubag") presenting predominantly with parkinsonism: a more benign phenotype?
January 2002, Movement disorders : official journal of the Movement Disorder Society,
M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
Eye movement abnormalities in a case of X-linked dystonia-Parkinsonism (lubag).
June 2004, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society,
M F Lew, and M Shindo, and C B Moskowitz, and K C Wilhelmsen, and S Fahn, and C H Waters
Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women.
August 1993, Neurology,
Copied contents to your clipboard!